Tomoyuki Aruga

Chitosan: An overview of biological activities, derivatives, properties, and current advancements in biomedical applications

Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer

Efficacy and toxicity of palbociclib in heavily treated patients with metastatic breast cancer

Phase I study of weekly nab‐paclitaxel combined with S‐1 in patients with human epidermal growth factor receptor type 2‐negative metastatic breast cancer